A promising scientific breakthrough amid research funding cuts
Trending
- Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis
- The Global Story
- Cancer screening shouldn’t stop at long-term care facility doors
- The Global Story – Will the new cancer vaccine survive RFK Jr’s America?
- Genome-wide CRISPR screens identify an RXR–MYLIP–LDLR axis regulating BH3 mimetic sensitivity in peripheral T-cell lymphomas
- Oxford cancer trial hopes to reduce risks for rare condition
- PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia
- NHS England to offer women ‘gamechanging’ free home testing kits for cervical cancer | Cervical cancer

